FDA Confirms 510(K) Path for Brainsway’s Deep TMS Device

Brainsway is pleased to report that the U.S. FDA has confirmed that the regulatory approval process for Brainsway’s Deep TMS device for the treatment of major depression disorder (MDD) will be the Pre-Market Notification 510(k) process.
MarketWatch